Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20275 | GS 0573 ( PMEDAP ) | 113852-41-8 | 98% Min. |  |
| GS 0573 is an antiviral compound that has been studied for potential treatment of Fel | ||||
| 6111905 | Blarcamesine HCl | 195615-84-0 | 98% Min. |  |
| Anavex2-73 is a muscarinic/σ1 ligand. ANAVEX2-73 (0.01-3.0 mg/kg i.p.) alleviated th | ||||
| 20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% |  |
| Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
| 11022 | WP-1130 | 856243-80-6 | 98% Min. |  |
| Degrasyn, also known as WP1130, is a small molecule that specifically and rapidly dow | ||||
| 20305 | ONC201 HCl | 1638178-82-1 | 98% Min. |  |
| ONC-201, also known as TIC10 and imipridone, is a potent, orally active, and stable s | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20314 | Obicetrapib | 866399-87-3 | 98% Min. |  |
| Obicetrapib (also known as AMG-899, TA-8995, and DEX-001) is a cholesteryl ester tran | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 1711223 | Asciminib HCl | 2119669-71-3 | ≧98.0% |  |
| Asciminib, also known as ABL001, is a potent allosteric inhibitor of BCR-ABL. | ||||
| 20474 | Tinlarebant ( LBS-008 ) | 1821327-95-0 | ≧98.0% |  |
| Tinlarebant (LBS-008) is a small-molecule inhibitor of retinol binding protein 4 (RBP | ||||
| 20517 | HM43239 | 2569527-64-4 | 98% Min. |  |
| HM43239 is an orally active small molecule inhibitor of FLT3 that selectively inhibit | ||||
| 20518 | BMS-986141 | 1478711-48-6 | 98% Min. |  |
| BMS-986141 is an Orally-Active Small-Molecule Antagonist of the Platelet Protease-Act | ||||